2020
DOI: 10.1016/j.eucr.2020.101433
|View full text |Cite
|
Sign up to set email alerts
|

Gestational choriocarcinoma presenting with bilateral kidney and lung metastases with unknown primary: An uncommon clinical scenario

Abstract: Gestational choriocarcinoma with kidney and lung metastases with delayed presentation after term pregnancy is rare event and not described frequently in literature. We describe a rare case of 24-year-old female with hematuria after 3 years of term delivery. Management includes chemotherapy and even renal embolization in case of life threatening hematuria.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…The most common presenting symptom of choriocarcinoma is gynecologic manifestations, mainly vaginal bleeding. Sometimes, the primary uterine tumor undergoes spontaneous necrosis or complete regression and the patient presents with extra-uterine manifestations in the later period due to metastasis [ 1 ]. Overall, about one third of the patients present with non-gynecological manifestations as a result of metastases.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The most common presenting symptom of choriocarcinoma is gynecologic manifestations, mainly vaginal bleeding. Sometimes, the primary uterine tumor undergoes spontaneous necrosis or complete regression and the patient presents with extra-uterine manifestations in the later period due to metastasis [ 1 ]. Overall, about one third of the patients present with non-gynecological manifestations as a result of metastases.…”
Section: Discussionmentioning
confidence: 99%
“…Even accompanied by multiple metastases, choriocarcinoma is extremely chemosensitive and the possibility of cure remains high [ 12 ]. Cure rates of 80–90 % may be achieved when combined with adjuvant radiotherapy or surgery [ 1 ]. The options of treatment for high-risk gestational trophoblastic neoplasia with multi-agent chemotherapy include MAC (Methotrexate, Actinomycin D, Cyclophosphamide or Clorambucile) or CHAMOMA (Hydroxyurea, Actinomycin D, Methotrexate, Folinic acid, Cytoxan, Vincristine, and Adriamycin).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation